Clinical Trial Shows Twice Yearly Injection to be 96 Percent Effective in HIV Prevention Dr. Bhumika Maikhuri2 Dec 2024 8:30 AM ISTResults from a recent Gilead-funded clinical trial (Purpose-2) led by physicians at Emory University and Grady Health System indicate that a...
WHO and Partners Strengthen Efforts Against Cervical Cancer Dr. Bhumika Maikhuri20 Nov 2024 8:45 AM ISTAs world leaders arrive in Rio de Janeiro, Brazil, for the G20 Summit this weekend, the city's iconic Christ the Redeemer statue will be illuminated...
New Nasal Vaccine May Reduce Whooping Cough Spread: Study Reveals Dr. Bhumika Maikhuri20 Nov 2024 8:00 AM ISTA new nasal vaccine developed by Tulane University may hold the key to reducing the spread of the highly contagious respiratory disease.Current...
Clinical Trial Finds Well Tolerated Vaccine for Aggressive Breast Cancer Dr. Bhumika Maikhuri15 Nov 2024 8:00 AM ISTA small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to...
Researchers Highlight the Best Time for RSV Vaccine During Pregnancy Dr. Bhumika Maikhuri13 Nov 2024 8:30 AM ISTCurrent guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)-which typically causes mild, cold-like...
WHO Identifies 17 Top Priority Pathogens for New Vaccine Development Dr. Bhumika Maikhuri11 Nov 2024 8:15 AM ISTA new study by the World Health Organization (WHO) lists 17 bacteria, viruses and parasites that regularly cause disease as top priorities for new...
Maternal Antibodies May Interfere with Malaria Vaccine Responses: Study Finds Dr. Bhumika Maikhuri28 Oct 2024 8:45 AM ISTMaternal antibodies passed across the placenta can interfere with the response to the malaria vaccine, which would explain its lower efficacy in...
Approximately 80 Percent Protection May be Provided by RSV Vaccine Against Severe Disease and Death: Study Suggests Dr. Bhumika Maikhuri21 Oct 2024 8:15 AM ISTA multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the respiratory syncytial virus...
NIH Clinical Trial Shows Mpox Vaccine Safe for Adolescents Dr. Bhumika Maikhuri21 Oct 2024 7:45 AM ISTA National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents found it was safe and generated an antibody response...
WHO Announces Fourth HPV Vaccine for Use in Single Dose Schedule Dr. Bhumika Maikhuri8 Oct 2024 8:30 AM ISTWHO announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine product, Cecolin has been confirmed for use in a single-dose schedule....
MMR Vaccine Most Effective Against Measles but May Wane Over Time: Lancet Public Health Dr. Bhumika Maikhuri30 Sept 2024 8:15 AM ISTBetween 2011 and 2019, the proportion of measles cases in adults who received two doses of the MMR vaccine in England increased from 1.9% (20/1064)...
MIT Study Shows That Two Dose Schedule May Make HIV Vaccine More Effective Dr. Bhumika Maikhuri24 Sept 2024 8:45 AM ISTIn a new study, the researchers have now found that they can achieve an immune response similar to multidose regimen, with just two doses, given one...
